MAXCYTE INC (MXCT)
US57777K1060 - Common Stock
ChartMill assigns a Buy % Consensus number of 88% to MXCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.44. This target is 96.56% above the current price.
MXCT was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about MXCT.
In the previous month the buy percentage consensus was at a similar level.
MXCT was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-23 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-03-13 | BTIG | Maintains | Buy -> Buy |
| 2024-03-13 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-11-29 | Craig-Hallum | Initiate | Buy |
| 2023-10-05 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-03-28 | Stephens & Co. | Reiterate | Overweight |
| 2022-08-15 | BTIG | Maintains | Buy |
| 2021-08-24 | William Blair | Initiate | Outperform |
| 2021-08-24 | BTIG | Initiate | Buy |
| 2021-08-24 | Stephens & Co. | Initiate | Overweight |
| 2021-08-24 | Stifel | Initiate | Buy |
| 2021-08-24 | Cowen & Co. | Initiate | Outperform |